AMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that the Company will host a conference call and live webcast on Monday, June 15, 2015, at 10:00 AM EDT (4:00 PM CEST) to review highlights from the two oral presentations on the luspatercept clinical trials in myelodysplastic syndromes and beta-thalassemia given at the 20th Congress of the European Hematology Association.
Help employers find you! Check out all the jobs and post your resume.
